Peak Pharmaceuticals, Inc. operates as a biopharmaceutical and nutraceutical company in the United States. The company focuses to develop, manufacture, market, and sell medicinal products based on extracts from hemp. It is involved in the development of over-the-counter, THCfree, hemp based products for human market for the prevention and alleviation of symptoms associated with inflammatory and auto-immune diseases. The company was formerly known as Cannabis Therapy Corporation and changed its name to Peak Pharmaceuticals, Inc. in December 2014. Peak Pharmaceuticals, Inc. was incorporated in 2007 and is based in Scottsdale, Arizona.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryCannabis
SectorMedical
CIKN/A
Phone480-659-6404
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees1
Next Earnings DateN/A
OptionableNot Optionable
Peak Pharmaceuticals (OTCMKTS:PKPH) Frequently Asked Questions
What is Peak Pharmaceuticals' stock symbol?
Peak Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PKPH."
Has Peak Pharmaceuticals been receiving favorable news coverage?
News headlines about PKPH stock have been trending positive on Thursday, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Peak Pharmaceuticals earned a media sentiment score of 2.3 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Peak Pharmaceuticals.
Who are some of Peak Pharmaceuticals' key competitors?
Some companies that are related to Peak Pharmaceuticals include Canopy Growth (WEED), Canopy Growth (CGC), Innovative Industrial Properties (IIPR), OrganiGram (OGI), Emblem (EMC), GrowGeneration (GRWG), ICC Labs (ICC), Bioventix (BVXP), KushCo (KSHB), 22nd Century Group (XXII), mCig (MCIG), General Cannabis (CANN), Terra Tech (TRTC), Grow Capital (GRWC) and Nemus Bioscience (NMUS).
What other stocks do shareholders of Peak Pharmaceuticals own?
Who are Peak Pharmaceuticals' key executives?
Peak Pharmaceuticals' management team includes the folowing people:
- Mr. Neil T. Reithinger, CEO, Pres, CFO, Principal Accounting Officer, Treasurer, Sec. & Director (Age 49)
How do I buy shares of Peak Pharmaceuticals?
Shares of PKPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Peak Pharmaceuticals' stock price today?
One share of PKPH stock can currently be purchased for approximately $0.01.
How big of a company is Peak Pharmaceuticals?
What is Peak Pharmaceuticals' official website?
How can I contact Peak Pharmaceuticals?
Peak Pharmaceuticals' mailing address is 14201 N. HAYDEN ROAD SUITE A-1, SCOTTSDALE AZ, 85260. The company can be reached via phone at 480-659-6404 or via email at [email protected]
MarketBeat Community Rating for Peak Pharmaceuticals (OTCMKTS PKPH)
MarketBeat's community ratings are surveys of what our community members think about Peak Pharmaceuticals and other stocks. Vote "Outperform" if you believe PKPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PKPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
